Evidence map›Paper›PMID 30700707›Full record

ArticleNature communications2019

Dual RNA-seq identifies human mucosal immunity protein Mucin-13 as a hallmark of Plasmodium exoerythrocytic infection.

Gregory M LaMonte, Pamela Orjuela-Sanchez, Jaeson Calla, Lawrence T Wang, Shangzhong Li, Justine Swann, Annie N Cowell, Bing Yu Zou, Alyaa M Abdel-Haleem Mohamed, Zaira Hellen Villa Galarce and 5 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
8.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 76 citations in OpenAlex.

  1. Article
  2. Revisiting Glutathione Transferases ofPharmaceuticals (Basel, Switzerland) · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Transcriptome profiling of intrahepatocyticFrontiers in genetics · 2025
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Single-cell RNA profiling ofFrontiers in cellular and infection microbiology · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 3 countries.

Gregory M LaMonteDepartment of Pediatrics, University of California, San Diego, School of Medicine, La Jolla, CA, 92093, USA.
Pamela Orjuela-SanchezDepartment of Pediatrics, University of California, San Diego, School of Medicine, La Jolla, CA, 92093, USA.
Jaeson CallaDepartment of Pediatrics, University of California, San Diego, School of Medicine, La Jolla, CA, 92093, USA.
Lawrence T WangDepartment of Pediatrics, University of California, San Diego, School of Medicine, La Jolla, CA, 92093, USA.
Shangzhong LiDepartment of Pediatrics, University of California, San Diego, School of Medicine, La Jolla, CA, 92093, USA.
Justine SwannDepartment of Pediatrics, University of California, San Diego, School of Medicine, La Jolla, CA, 92093, USA.
Annie N CowellDivision of Infectious Diseases, Department of Medicine, University of California San Diego, La Jolla, CA, 92093, USA.
Bing Yu ZouDepartment of Pediatrics, University of California, San Diego, School of Medicine, La Jolla, CA, 92093, USA.
Alyaa M Abdel-Haleem MohamedComputational Bioscience Research Centre (CBRC) and Biological and Environmental Sciences and Engineering (BESE) division, King Abdullah University of Science and Technology (KAUST), Thuwal, Saudi Arabia.
Zaira Hellen Villa GalarceLaboratorio ICEMR-Amazonia, Laboratorio de Investigación y Desarrollo, Facultad de Ciencias y Filosofia, Universidad Peruana Cayetano Heredia, Lima, Peru.
Marta MorenoLaboratorio ICEMR-Amazonia, Laboratorio de Investigación y Desarrollo, Facultad de Ciencias y Filosofia, Universidad Peruana Cayetano Heredia, Lima, Peru.
Carlos Tong RiosLaboratorio ICEMR-Amazonia, Laboratorio de Investigación y Desarrollo, Facultad de Ciencias y Filosofia, Universidad Peruana Cayetano Heredia, Lima, Peru.
Joseph M VinetzDivision of Infectious Diseases, Department of Medicine, University of California San Diego, La Jolla, CA, 92093, USA.
Nathan LewisDepartment of Pediatrics, University of California, San Diego, School of Medicine, La Jolla, CA, 92093, USA.
Elizabeth A WinzelerDepartment of Pediatrics, University of California, San Diego, School of Medicine, La Jolla, CA, 92093, USA. ewinzeler@ucsd.edu.
University of California, San Diego · USUniversidad Peruana Cayetano Heredia · PEKing Abdullah University of Science and Technology · SA

Funding

Sugar-feeding behavior of the malaria vector Nyssorhynchus darlingi and development of effective attractive toxic sugar baits (ATSB) to increase intervention success in PeruU19AI089681 · NIAID · YALE UNIVERSITY · PI VINETZ, JOSEPH M. · 2010 to 2023
$20.1M
University of California Launching Future Leaders in Global Health Research Training ProgramD43TW009343 · FIC · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CRAIG R COHEN, Sung-Jae Lee · 2017 to 2026
$14.7M
RESEARCH IN INFECTIOUS DISEASEST32AI007036 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI NIZET, VICTOR · 1985 to 2025
$9.2M
Unraveling the mammalian secretory pathway through systems biology and algorithm developmentR35GM119850 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LEWIS, NATHAN ENOCH · 2016 to 2025
$4.3M
Discovery of chemically validated malaria liver stage targetsR01AI090141 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI WINZELER, ELIZABETH A · 2011 to 2019
$3.4M
Translational Research Development for Endemic Infectious Diseases of AmazoniaD43TW007120 · FIC · YALE UNIVERSITY · PI VINETZ, JOSEPH M. · 2004 to 2020
$3.0M
Defining the targets of broad intervention antimalarial agentsR01AI103058 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI WINZELER, ELIZABETH A · 2013 to 2016
$2.6M
FIC NIH HHS D43 TW007120FIC NIH HHS D43 TW009343NIAID NIH HHS R01 AI090141NIAID NIH HHS R01 AI103058NIAID NIH HHS T32 AI007036NIAID NIH HHS U19 AI089681NIGMS NIH HHS R35 GM119850NIH HHS D43TW007120NIH HHS T32 AI 007036NIH HHS U19AI089681
6 · The paper itself

Abstract

The exoerythrocytic stage of Plasmodium infection is a critical window for prophylactic intervention. Using genome-wide dual RNA sequencing of flow-sorted infected and uninfected hepatoma cells we show that the human mucosal immunity gene, mucin-13 (MUC13), is strongly upregulated during Plasmodium exoerythrocytic hepatic-stage infection. We confirm MUC13 transcript increases in hepatoma cell lines and primary hepatocytes. In immunofluorescence assays, host MUC13 protein expression distinguishes infected cells from adjacent uninfected cells and shows similar colocalization with parasite biomarkers such as UIS4 and HSP70. We further show that localization patterns are species independent, marking both P. berghei and P. vivax infected cells, and that MUC13 can be used to identify compounds that inhibit parasite replication in hepatocytes. This data provides insights into host-parasite interactions in Plasmodium infection, and demonstrates that a component of host mucosal immunity is reprogrammed during the progression of infection.

Indexed as

Carcinoma, HepatocellularCell LineCells, CulturedHepatocytesHost-Parasite InteractionsHSP70 Heat-Shock ProteinsHumansImmunity, MucosalLiver NeoplasmsMalariaMucinsPlasmodium bergheiHSP70 Heat-Shock ProteinsMUC13 protein, humanMucins

Identifiers

PMID30700707
PMCPMC6353872
OpenAlexW2914822739

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.